Amling M - Search Results

1

Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor.

Rauch A, Seitz S, Baschant U, Schilling AF, Illing A, Stride B, Kirilov M, Mandic V, Takacz A, Schmidt-Ullrich R, Ostermay S, Schinke T, Spanbroek R, Zaiss MM, Angel PE, Lerner UH, David JP, Reichardt HM, Amling M, Schütz G, Tuckermann JP. Rauch A, et al. Among authors: amling m. Cell Metab. 2010 Jun 9;11(6):517-31. doi: 10.1016/j.cmet.2010.05.005. Cell Metab. 2010. PMID: 20519123 Free article.

2

Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass.

Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. Ducy P, et al. Among authors: amling m. Cell. 2000 Jan 21;100(2):197-207. doi: 10.1016/s0092-8674(00)81558-5. Cell. 2000. PMID: 10660043 Free article.

3

Progressive increase in bone mass and development of odontomas in aging osteopetrotic c-src-deficient mice.

Amling M, Neff L, Priemel M, Schilling AF, Rueger JM, Baron R. Amling M, et al. Bone. 2000 Nov;27(5):603-10. doi: 10.1016/s8756-3282(00)00373-2. Bone. 2000. PMID: 11062345 Free article.

4

Biologically and chemically optimized composites of carbonated apatite and polyglycolide as bone substitution materials.

Linhart W, Peters F, Lehmann W, Schwarz K, Schilling AF, Amling M, Rueger JM, Epple M. Linhart W, et al. Among authors: amling m. J Biomed Mater Res. 2001 Feb;54(2):162-71. doi: 10.1002/1097-4636(200102)54:2<162::aid-jbm2>3.0.co;2-3. J Biomed Mater Res. 2001. PMID: 11093175

5

[Leptin: factor in the central nervous system regulation of bone mass. Development of a new understanding of bone remodeling, skeletal reconstruction, skeletal preservation and skeletal repair].

Amling M, Schilling AF, Haberland M, Rueger JM. Amling M, et al. Orthopade. 2001 Jul;30(7):418-24. doi: 10.1007/s001320170072. Orthopade. 2001. PMID: 11515179 German.

6

Brain and bone: central regulation of bone mass. A new paradigm in skeletal biology.

Haberland M, Schilling AF, Rueger JM, Amling M. Haberland M, et al. Among authors: amling m. J Bone Joint Surg Am. 2001 Dec;83(12):1871-6. doi: 10.2106/00004623-200112000-00016. J Bone Joint Surg Am. 2001. PMID: 11741068 Review. No abstract available.

7

Cloning and functional characterization of resistin-like molecule gamma.

Schinke T, Haberland M, Jamshidi A, Nollau P, Rueger JM, Amling M. Schinke T, et al. Among authors: amling m. Biochem Biophys Res Commun. 2004 Feb 6;314(2):356-62. doi: 10.1016/j.bbrc.2003.12.100. Biochem Biophys Res Commun. 2004. PMID: 14733912

8

Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects.

Kenner L, Hoebertz A, Beil FT, Keon N, Karreth F, Eferl R, Scheuch H, Szremska A, Amling M, Schorpp-Kistner M, Angel P, Wagner EF. Kenner L, et al. Among authors: amling m. J Cell Biol. 2004 Feb 16;164(4):613-23. doi: 10.1083/jcb.200308155. Epub 2004 Feb 9. J Cell Biol. 2004. PMID: 14769860 Free PMC article.

9

Resorbability of bone substitute biomaterials by human osteoclasts.

Schilling AF, Linhart W, Filke S, Gebauer M, Schinke T, Rueger JM, Amling M. Schilling AF, et al. Among authors: amling m. Biomaterials. 2004 Aug;25(18):3963-72. doi: 10.1016/j.biomaterials.2003.10.079. Biomaterials. 2004. PMID: 15046886

10

The Fos-related antigen Fra-1 is an activator of bone matrix formation.

Eferl R, Hoebertz A, Schilling AF, Rath M, Karreth F, Kenner L, Amling M, Wagner EF. Eferl R, et al. Among authors: amling m. EMBO J. 2004 Jul 21;23(14):2789-99. doi: 10.1038/sj.emboj.7600282. Epub 2004 Jul 1. EMBO J. 2004. PMID: 15229648 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

463 results

Search Page

Filters